You are here

Our science / Clinical Trials / Find a Trial / NCT00365924

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Back to Search Print Save as PDF Bookmark Trial

NCT00365924

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Buenos Aires, , C1055AAK Argentina
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoporosis
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
55-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Postmenopausal women with osteoporosis

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any therapies or products affecting bone turnover within 12 months of Screening.

- Bisphosphonate treatment >1 month in total duration at any time in the past.

- In addition, patients must be bisphosphonate-treatment-free for at least 12 months
prior to Screening.

NCT00365924
Pfizer
Completed
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Osteopenia, Osteoporosis, Bone Disease
Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.
NCT01293487
All Genders
55+
Years
Multiple Sites
Osteoporosis
Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD
NCT00752557
Females
65+
Years
Multiple Sites
Osteoporosis
Study Evaluating Changes In Mammographic Breast Density
NCT00774267
Females
40+
Years
Multiple Sites
Osteoporosis
Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
NCT00481169
Females

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now